Liprolog is a range of insulin medicines used to treat patients who have diabetes and need insulin to keep their blood glucose (sugar) level controlled, including patients whose diabetes has just been diagnosed. Liprolog medicines contain the active substance insulin lispro on its own or combined with protamine to make it longer acting: * Liprolog (100 units/ml): standard\-strength insulin lispro (fast\-acting); * Liprolog (200 units/ml): high\-strength insulin lispro (fast\-acting); * Liprolog Mix25 (100 units/ml): 25% insulin lispro (fast\-acting) and 75% insulin lispro protamine (longer\-acting); * Liprolog Mix50 (100 units/ml): 50% insulin lispro (fast\-acting) and 50% insulin lispro protamine (longer\-acting).
Therapeutic Indication
For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilisation of diabetes mellitus.
Therapeutic Area (MeSH)
ATC Code
A10AB04
ATC Item
N/A
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
EMA Name
Liprolog
Medicine Name
Liprolog
Aliases
N/ANo risk management plan link.
